VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 168 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $148,000 | -8.1% | 14,975 | +1.4% | 0.56% | +19.0% |
| Q2 2022 | $161,000 | -5.8% | 14,766 | -2.2% | 0.47% | +20.4% |
| Q1 2022 | $171,000 | -43.8% | 15,101 | -22.0% | 0.39% | -19.1% |
| Q4 2021 | $304,000 | -22.4% | 19,359 | -15.4% | 0.49% | +2.3% |
| Q3 2021 | $392,000 | -38.9% | 22,878 | -23.4% | 0.48% | -36.9% |
| Q2 2021 | $642,000 | +33.8% | 29,886 | -6.5% | 0.75% | +42.6% |
| Q1 2021 | $480,000 | +130.8% | 31,959 | +104.4% | 0.53% | +132.6% |
| Q3 2019 | $208,000 | +22.4% | 15,634 | +29.7% | 0.23% | +158.0% |
| Q2 2019 | $170,000 | – | 12,052 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |